TGFbeta2 mediates rapid inhibition of calcium influx in identified cholinergic basal forebrain neurons

Sylvain Williams1, Serhiy Souchelnytskyi, Marc Danik

  • 1Douglas Hospital Research Center, McGill University, Montreal, Quebec, Canada. wilsyl@douglas.mcgill.ca

Insights

Transforming growth factor-beta 2 (TGFbeta2) rapidly inhibits calcium influx in basal forebrain cholinergic neurons. This neurotransmitter-like action occurs via an atypical Smad2/3 signaling pathway, suggesting novel roles in neuronal excitability.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Molecular Signaling

Background:

  • Transforming growth factors betas (TGFbetas) are recognized for their roles in neuronal survival.
  • Their rapid, neurotransmitter-like actions within the central nervous system (CNS) remain largely unexplored.
  • TGFbetas can be upregulated in various neurological diseases.

Purpose of the Study:

  • To investigate the acute, neurotransmitter-like effects of TGFbetas on central nervous system neurons.
  • To elucidate the specific actions of TGFbeta2 on calcium influx in basal forebrain neurons.
  • To identify the signaling mechanisms underlying TGFbeta2's rapid effects.

Main Methods:

  • Utilized fura-2AM to measure calcium influx in enzymatically dissociated basal forebrain neurons.
  • Applied TGFbeta1 and TGFbeta2 to assess their effects on potassium-evoked calcium influx.
  • Employed single-cell RT-PCR to identify neuronal phenotypes.
  • Investigated signaling pathways using whole-cell recordings of calcium currents and Smad2/3 peptide antagonists.

Main Results:

  • TGFbeta2, but not TGFbeta1, acutely and reversibly inhibited K(+)-evoked calcium influx within seconds.
  • TGFbeta2-responsive neurons were identified as having a cholinergic phenotype.
  • TGFbeta2-mediated calcium current reduction was insensitive to GTPgammaS but blocked by a Smad2/3 antagonist.

Conclusions:

  • TGFbeta2 exhibits rapid, neurotransmitter-like regulation of excitability in basal forebrain cholinergic neurons.
  • The signaling mechanism involves an atypical pathway dependent on Smad2/3.
  • These findings reveal a novel function for TGFbeta2 in modulating neuronal activity.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...